Therapeutic areas

Our vision is to provide innovative solutions for disabling conditions and to improve patient care – it is at the heart of everything we do.

At Ipsen, our licensed medicines and R&D cover a range of therapeutic areas. However, all are focused on curing disease and relieving suffering, hoping to bring real value to the healthcare community.

Our primary focus lies in three main areas: oncology (cancers), neurosciences (diseases of the nervous system and the use of therapeutic neurotoxins) and rare diseases.

Oncology

Oncology

Every two minutes someone in the UK is diagnosed with canceri. Ipsen is committed to developing new treatments with the ability to improve and extend lives of those affected.

 

i Cancer Research UK: Cancer Statistics for the UK. Key fact available here. Accessed March 2019.

Oncology

Tackling cancer head-on

Although often talked about generally, ‘cancer’ actually describes a diverse range of diseases. Each type of cancer is typically characterised by the presence of abnormal cells that divide in an uncontrolled way.Some cancers can be surgically removed or treated successfully, particularly if they are detected early. However, for people with a cancer that may be more advanced or complicated to treat, options can be limited.ii

ii Cancer Research UK – what is cancer? Key facts available at https://www.cancerresearchuk.org/about-cancer/what-is-cancer Accessed March 2019

Neuroscience

Neuroscience

At Ipsen we have pioneered research in the area of neuroscience for decades and remain committed to providing patients with innovative therapeutic solutions.

Neuroscience

Searching for solutions to debilitating neurological conditions

Neurological conditions are disorders of the brain, spinal cord or nerves. They can have a range of causes including genetic factors, traumatic injury and infection. The causes of some of these conditions are still not well understood.

Some of these conditions are debilitating and many of them can severely affect a person’s quality of life .i

 

iThe Neurological Alliance: Living with a Neurological Condition. Key fact available at: https://www.neural.org.uk/about-neurological-conditions/Accessed March 2019

Rare diseases

Rare diseases

In the EU, a disease is considered to be rare when the number of people affected is less than 5 per 10,000.Ipsen is committed to translating scientific progress into clinically meaningful medicines for people suffering from rare conditions.

iWHO. Priority diseases and inclusion. Key fact available at http://www.who.int/medicines/areas/priority_medicines/Ch6_19Rare.pdf?ua=1 Accessed March 2019.

Rare diseases

Addressing areas of unmet need

Ipsen’s work in rare diseases currently focuses on a number of endocrine diseases, looking at how we can address areas of high unmet need for people affected by hormone and metabolic imbalances.

The endocrine system is comprised of a series of glands, which are each responsible for secreting a specific type of hormone into the bloodstream. Endocrine diseases occur when these glands make either too much or too little of their respective hormone and can cause issues with growth, development, metabolism, sexual function, and mood.ii

 

iiThe Christie NHS Trust – endocrine tumours. Key fact available at https://www.christie.nhs.uk/patients-and-visitors/your-treatment-and-care/types-of-cancer/endocrine-tumours/ Accessed March 2019

Other therapeutic areas

Other therapeutic areas

Every day we strive to support positive change for patients and health services across the UK, working in close partnership to deliver meaningful results. At Ipsen, our licensed medicines and R&D cover a range of therapeutic areas.

We are committed to improving quality of life for patients and discovering new solutions for targeted debilitating diseases.

Other therapeutic areas

Audience: General public
ALL-UK-000825
Date of preparation: April 2019

© Ipsen Group 2019